Status:
COMPLETED
Allopurinol Effect on MDA,NO,KIM-1 Urine Levels, RI and Renal Elastography in Kidney Stone Patients Post ESWL
Lead Sponsor:
Sanglah General Hospital
Conditions:
Kidney Calculi
Eligibility:
All Genders
18-59 years
Phase:
PHASE4
Brief Summary
Extracorporeal shock wave lithotripsy (ESWL) is accepted as the first treatment choice for most urinary stones. Still, it has adverse effects on the kidneys. The mechanism underlying the shock wave in...
Detailed Description
Subjects with kidney stones who met the criteria were given a detailed explanation about this study by the research team, then followed by signing the informed consent. History was taken along with ph...
Eligibility Criteria
Inclusion
- Patient with renal stone who meet ESWL criteria
- Age 18 to 59 years old
- Consent to join this study
Exclusion
- Patient with Diabetes Melitus
- Patient with hypertension
- Patient with Chronic Kidney Disease stage IV and stage V
- Patient with urinary tract infection
- Patient with obesity
- Patient with uric acid more than 9mg/dL
Key Trial Info
Start Date :
August 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 20 2021
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT05414669
Start Date
August 6 2020
End Date
April 20 2021
Last Update
June 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanglah General Hospital
Denpasar, Bali, Indonesia, 80114